Published in Oncology Business Week, May 27th, 2007
"We questioned this argument and hypothesized that tobramycin once daily was as efficacious as three times daily. We conducted a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.